As of 2024-12-12, the Relative Valuation of E-Therapeutics PLC (ETX.L) is (32.75) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 9.00 GBP, the upside of E-Therapeutics PLC based on Relative Valuation is -463.9%.
The range of the Relative Valuation is (32.80) - (29.40) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.8x - 37.3x | 31.0x |
| Forward P/E multiples | 14.8x - 22.3x | 18.6x |
| Fair Price | (32.80) - (29.40) | (32.75) |
| Upside | -464.5% - -426.6% | -463.9% |
| Date | P/E |